Formation Bio has appointed Michael Ellers as Chief Scientific Officer
The biotechnology company Formation Bio has appointed Michael Ehlers as Chief Scientific Officer and Head of Research and Development, according to STAT News.
Prior to joining Formation Bio, Ellers served as CEO and president of Ascidian Therapeutics, which he founded.
The appointment was mentioned in STAT News’ regular column on personnel changes in the pharmaceutical industry. In this column, the publication features one person each week. The focus is on new hires, resignations, promotions, and transfers. Information about Elers is included in this particular installment.
For more breaking news, follow the UA.News Telegram channel.
The article was published on August 14, 2026. It was written by Ed Silverman, a senior reporter and columnist at Pharmalot. According to the publication, he writes about prescription drug prices, accessibility, patents, legal disputes, and legislation.
He is also the author of the Pharmalittle morning newsletter and the Pharmalot afternoon newsletter.
